1-1 of 1
John M. Zoscak, III
Close
Sort by
Journal Articles

Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials

Clinical Trials & Observations
Taylor Bucy, John M. Zoscak, III, Motomi Mori, Uma Borate
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4055–4064.
https://doi.org/10.1182/bloodadvances.2019000532
Published: 2019
Includes: Supplemental data